Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Familial Atherosclerosis Treatment Study
NCT00000512Phase 3Completed
- Sponsor
- University of Washington
- Start
- Jan 1984
- Primary completion
- Aug 1989
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of lovastatin and niacin in Coronary atherosclerosis (CAD) and hyperlipidemia (3 arms), sponsored by University of Washington. Primary endpoint: Change in the Mean Severity of Proximal Stenosis at 2.5 years. Started Jan 1984; status: completed.
02
Drugs
lovastatinniacin
03
Conditions
Coronary atherosclerosis (CAD)hyperlipidemia
Beyond the preview
Go deeper on NCT00000512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000512.